NK:

Pei Guo1, Liyuan Zhong1, Tao Wang1

  • 1Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

PubMed
概括

肝细胞癌 (HCC) 治疗正在通过免疫疗法推进. 这篇评论探讨了自然杀手 (NK) 细胞.